Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
06/2010
06/09/2010CN101204460B Remedy for varicocele
06/09/2010CN101199761B Drug for treating arteriosclerosis
06/09/2010CN101199734B Shuxin capsule for treating cardiac angina induced by CAD
06/09/2010CN101194947B Chinese medicine for treating angiocardiopathy
06/09/2010CN101172147B Health-care medicinal liquor capable of lowering blood pressure
06/09/2010CN101167910B Oral liquid traditional Chinese medicine for treating cerebral thrombus sequelae
06/09/2010CN101167763B Monascus and total ginkgolide composition for preventing and treating cardiovascular and cerebrovascular diseases
06/09/2010CN101129513B Method for preparing crataegutt sustained-release formulation by using separation - formulated product coupling technique
06/09/2010CN101073599B Total tanshinone and total phenolic acid extract in red-rooted salvia root and its production
06/09/2010CN101062294B Method for detecting the quality of the medicine combination for treating cerebral apoplexy and vasculitis
06/09/2010CN101057619B Health tea to help producing saliva and slaking thirst, softening blood vessel, promoting blood circulation
06/09/2010CN101029051B (pyrido/thieno)-(f)-oxazepin-5-one derivatives as positive modulators of the AMPA receptor
06/08/2010US7732641 Formoterol tartrate process and polymorph
06/08/2010US7732622 Naphthalene derivatives
06/08/2010US7732617 Tocopherol derivatives and uses thereof
06/08/2010US7732610 Heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-bacterial agents
06/08/2010US7732596 2-( beta -D-Glucopyranosyl)-4-(2-phenylethyl)benzo[b]thiophene; prevention or treatment of a disease associated with hyperglycemia such as diabetes, postprandial hyperglycemia, impaired glucose tolerance, diabetic complications or obesity
06/08/2010US7732588 Expression vector comprising nucleotide sequences coding tumor necrosis factor receptor protein (TWEAK) for mediated by angiogenesis, such as solid tumors and vascular deficiencies of cardiac or peripheral tissue
06/08/2010US7732488 Marine oil derived ethyl ester of eicosapentaenoic acid and docosahexaenoic acid, with specified reduced levels of brominated flame retardants; not a health supplement; treat hypertriglyceridaemia
06/08/2010US7732487 Administering calcium channel modulators such as 13,14-dihydro 15-keto-16,16-difluoroprostaglandin E1, for prophylaxis of brain, cardiovascular, gastrointerstinal, respiratory system, vision or liver disorders
06/08/2010US7732484 Use of selective adenosine A1 receptor allosteric enhancers to manipulate angiogenesis
06/08/2010US7732459 CCR1 antagonists and methods of use therefor
06/08/2010US7732458 Methods for preparing dehydrocavidine, dehydroapocavidine or their composition, their use and medicinal composition containing them
06/08/2010US7732456 such as 4-benzyloxy-1-{4-[2-(dimethylamino)ethoxy]phenyl}-1H-pyridin-2-one, that as antagonists to melanin concentrating hormone receptors, used for treating cardiovascular, nervous system, metabolic, reproductive system, respiratory system and gatrointestinal disorders
06/08/2010US7732439 Diamino-substituted phenothiazinium compound; antimicrobial photosensitisers effective against Gram negative bacteria, Gram positive bacteria; photodynamic therapy
06/08/2010US7732437 Such as 3-[2-[4-(11,12-dihydro-6H-benzimidazo[2,1-b][3]benzazepin-6-yl)-2-(phenyl-methyl)-1-piperidinyl]ethyl]-2,10-dimethyl pyrimido[1,2- alpha ]benzimidazol-4(10H)-one
06/08/2010US7732413 1,4-Diphenyl-3-substituted azetidin-2-ones; can be metabolized in vivo to form a sterol and/or stanol absorption inhibitor and a sterol biosynthesis inhibitor for treatment of atherosclerosis, hypercholesterolemia, or sitosterolemia
06/08/2010US7732411 Methods of therapy with thrombin derived peptides
06/08/2010US7732146 Method for screening an agent that modulates activity of macrophage migration inhibitory factor
06/08/2010US7731955 Using lactoperoxidase composition as a therapeutic treatment for rheumatoid arthritis, sepsis, myleoma and influenza infection
06/08/2010CA2479642C 4-anilino quinazoline derivatives as antiproliferative agents
06/08/2010CA2440553C 4-(2-butylamino)-2,7-dimethyl-8-(2-methyl-6-methoxypyrid-3-yl)pyrazolo-[1,5-a]-1,3,5-triazine, its enantiomers and pharmaceutically acceptable salts as corticotropin releasing factor receptor ligands
06/08/2010CA2440213C Method for improving the well-being of poultry by in-ovo injection of carnitine
06/08/2010CA2439241C Bipiperidinyl-derivatives and their use as chemokine receptors inhibitors
06/08/2010CA2434972C Implantable device containing resorbable matrix material and anti-proliferative drugs for preventing or treating failure of hemodialysis vascular access and other vascular grafts
06/08/2010CA2431983C Novel 1,2-diphenylazetidinones, processes for their preparation, medicaments comprising these compounds and their use for treating impaired lipid metabolism
06/08/2010CA2403674C The use of t3 for treating congestive heart failure
06/08/2010CA2369300C Water-soluble compositions of bioactive lipophilic compounds
06/03/2010WO2010062824A2 Enhanced bioactive formulations of resveratrol
06/03/2010WO2010062692A1 Combination of morphinan compounds and antidepressant for the treatment of pseudobulbar affect, neurological diseases, intractable and chronic pain and brain injury
06/03/2010WO2010062690A1 Combination of morphinan compounds and antidepressant for the treatment of pseudobulbar affect, neurological diseases, intractable and chronic pain and brain injury
06/03/2010WO2010062557A2 Multimodal imaging of atherosclerotic plaque targeted to lox-1
06/03/2010WO2010062122A2 Composition for preventing or treating artherosclerosis
06/03/2010WO2010061931A1 Cyclobutyl purine derivative, angiogenesis promoting agent, lumenization promoting agent, neurocyte growth promoting agent, and drug
06/03/2010WO2010061915A1 Novel polypeptide having angiogenesis-inducing activity and antibacterial activity, and use thereof for medical purposes
06/03/2010WO2010061903A1 Pyrimidine derivative and pyridine derivative both having pi3k inhibitory activity
06/03/2010WO2010061787A1 Beauveriolide having acat-2 inhibitory activity
06/03/2010WO2010061180A1 Quinoline derivatives as p13 kinase inhibitors
06/03/2010WO2010061074A1 Indole derivatives, method for preparing same and pharmaceutical compositions containing same
06/03/2010WO2010060972A1 Erk1/2 phosphorylation site specific antibody
06/03/2010WO2010060934A2 Cnnm proteins and uses thereof
06/03/2010WO2010060891A1 Rocaglaol derivatives as cardioprotectant agents and as antineoplastic agents
06/03/2010WO2010060874A1 Phosphodiesterase type iii (pde iii) inhibitors or ca2+-sensitizing agents for the treatment of hypertrophic cardiomyopathy
06/03/2010WO2010060387A1 The five crystal forms of the nicousamide, the preparation methods, the pharmaceutical compositions and the uses thereof
06/03/2010WO2010060266A1 Neuregulin and cardiac stem cells
06/03/2010WO2010060265A1 Neuregulin peptides and their use
06/03/2010WO2010060199A1 Transdermally administered aliskiren
06/03/2010WO2010041017A3 Chewable gelled emulsions
06/03/2010WO2010040803A3 Kv1.3 channel blocking substances for the treatment of diseases associated with intimal hyperplasia
06/03/2010WO2010033560A3 Sur1 inhibitors for therapy
06/03/2010WO2010009210A3 Acetylsalicyclic acid derivatives useful to treat metabolic syndromes
06/03/2010WO2009109654A8 1-benzyl-3-hydr0xymethylindaz0le derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, and cx3cr1
06/03/2010US20100138939 Pig model for atherosclerosis
06/03/2010US20100137976 Systems and Methods for Treating Heart Tissue Via Localized Delivery of Parp Inhibitors
06/03/2010US20100137449 Substituted 1,3-cyclopentadione multi-target protein kinase modulators of cancer, angiogenesis and the inflammatory pathways associated therewith
06/03/2010US20100137436 Bipolar trans carotenoid salts and their uses
06/03/2010US20100137424 Pharmaceutical compositions comprising nebivolol or a nebivolol analogue
06/03/2010US20100137422 Novel phenanthrenequinone-based compound and pharmaceutical composition containing the same for the treatment or prevention of disease involving metabolic syndrome
06/03/2010US20100137418 Method for treating atherosclerosis or restenosis using microtubule stabilizing agent
06/03/2010US20100137414 Modulation of Factor 11 Expression
06/03/2010US20100137401 2-methylprop anamides and their use as pharmaceuticals
06/03/2010US20100137400 Pharmaceutical formulation containing an hmg-coa reductase inhibitor and method for the preparation thereof
06/03/2010US20100137397 Chemical Compounds
06/03/2010US20100137390 1,3-Dihydroimidazole-2-Thione Derivatives as Inhibitors of Dopamine-Beta-Hydroxylase
06/03/2010US20100137387 Beta-keto-amide derivatives useful as ion channel modulators
06/03/2010US20100137381 Acetamide derivatives as potassium channel modulators
06/03/2010US20100137377 Novel compounds
06/03/2010US20100137371 Novel Pharmaceutical Compounds
06/03/2010US20100137364 6-Aminoisoquinoline Compounds
06/03/2010US20100137363 Substituted Indoles And Methods Of Their Use
06/03/2010US20100137360 Trpv1 antagonists
06/03/2010US20100137352 Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders
06/03/2010US20100137350 Methods for preparing dehydrocavidine, dehydroapocavidine or their composition, their use and medicinal compositon containing them
06/03/2010US20100137329 Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and use of same as inhibitors of the faah enzyme
06/03/2010US20100137325 Biphenyl compounds useful as muscarinic receptor antagonists
06/03/2010US20100137324 Rho-kinase inhibitors
06/03/2010US20100137321 IMIDAZO[1,2-a]AZINES AND THEIR USE AS PHARMACEUTICALS
06/03/2010US20100137315 Sphingosine Kinase Inhibitors and Methods of Their Use
06/03/2010US20100137310 Renin inhibitors
06/03/2010US20100137308 Quinoxaline Compounds and Use Thereof
06/03/2010US20100137288 Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, pyrazolopyridines, isothiazolopyridines, and preparation and uses thereof
06/03/2010US20100137285 Small molecule modulators of cytokine activity
06/03/2010US20100137284 Compositions for the Treatment and Prevention of Heart Disease and Methods of Using Same
06/03/2010US20100137281 Heterocyclic compound and use thereof
06/03/2010US20100137274 Rivaroxaban and derivatives, synthesis; atherosclerosis; arthritis; Alzheimer's disease or cancer
06/03/2010US20100137273 Novel 2-Azetidinone Derivatives As Cholesterol Absorption Inhibitors For The Treatment Of Hyperlipidaemic Conditions
06/03/2010US20100137261 Method for treating aortic stenosis with non-antibacterial tetracycline formulations
06/03/2010US20100137255 Creatine phosphate analog prodrugs, compositions and uses thereof
06/03/2010US20100137244 Preparation and utility of hmg-coa reductase inhibitors
06/03/2010US20100137224 Method of reducing injury to mammalian cells
1 ... 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 ... 1595